Healthcare - Biotechnology - NASDAQ - CH
$ 48.83
-6.99 %
$ 3.08 B
Market Cap
-38.45
P/E
Price Target
Average
63.83%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
32.55%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
MoonLake Immunotherapeutics
Wall Street analysts predict an average 1-year price target for MLTX of $80 , with forecasts ranging from a low of $62 to a high of $100 .
MLTX Lowest Price Target
Wall Street Target
62 USD
26.97%
MLTX Average Price Target
Wall Street Target
80 USD
63.83%
MLTX Highest Price Target
Wall Street Target
100 USD
104.79%
REVENUE FORECAST
Revenue Forecast Chart MLTX
EBIT FORECAST
EBIT Forecast Chart MLTX
NET INCOME FORECAST
Net Income Chart MLTX